SJP Biotec GmbH
PrivateCompany Overview
SJP Biotec GmbH is a clinical-stage precision oncology company that develops targeted therapies for refractory cancers using a Selective Translation Regulatory Inhibitor (STRI) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biopharmaceuticalsmall molecule inhibitorsantibody-drug conjugatesADCtargeted cancer therapyprotein degradationdrug discoveryprecision medicineclinical-stage biotechtranslational researchoncology pipelineRAS inhibitorsbiotech startupdrug developmenttherapeutic modalities
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SJP Biotec GmbH Comparables
Compare SJP Biotec GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 76% | |
| Bristol Myers Squibb | 74% | |
| STORM Therapeutics | 72% | |
SJP Biotec GmbH Funding Rounds
Historical fundraising activity
SJP Biotec GmbH Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SJP Biotec GmbH's valuation, stock price, and market status.
See something wrong or outdated?